S&P Biotech Bear -3X ETF Direxion (NY: LABD )

5.660 -0.100 (-1.74%)

Streaming Delayed Price Updated: 1:45 PM EST, Nov 4, 2024 Add to My Watchlist

Price and Volume

Volume	18,035,522
Open	5.830
Bid (Size)	5.650 (526)
Ask (Size)	5.660 (1,045)
Prev. Close	5.760
Today's Range	5.610 - 5.990
52wk Range	5.110 - 27.24
Shares Outstanding	126,160
Dividend Yield	13.57%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

EXCLUSIVE: Beyond The Magnificent Seven — Direxion's Egilinsky Reveals Top Sector Picks

August 30, 2024

Direxion's Ed Egilinsky says there are several sectors could be impacted in the current rotation trade environment.

Via Benzinga

5 Inverse ETFs That Gained More Than 20% in April

May 01, 2024

The U.S. stock market wrapped up April with losses, snapping a five-month winning streak and marking the market’s worst month of 2024.

Via Talk Markets

Performance

YTD	-39.72%	-39.72%
1 Month	-6.91%	-6.91%
3 Month	-19.72%	-19.72%
6 Month	-30.47%	-30.47%
1 Year	-74.55%	-74.55%

More News

5 Leveraged/Inverse ETFs That Gained More Than 40% In Q3

October 02, 2023

Via Talk Markets

5 Inverse ETFs That Gained In Double Digits In August

September 03, 2023

Via Talk Markets

Inverse ETFs Soar as Market Turns Sour

August 09, 2023

Via Talk Markets

Want Diversified Upside in Biotechnology? Check out LABU

March 22, 2023

Via MarketBeat

5 Best Inverse-Leveraged ETFs Of February

March 01, 2023

Via Talk Markets

Stocks See Worst Day in 2 Years: Inverse ETFs Shine

May 19, 2022

Via Talk Markets

5 Inverse ETFs Enjoying A Rally This Year

April 19, 2022

Via Talk Markets

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

December 07, 2021

Via InvestorPlace

5 Leveraged/Inverse ETFs Up More Than 15% in November

December 02, 2021

Via Talk Markets

7 Inverse ETFs Riding High on Nasdaq Sell-Off

May 11, 2021

Via Talk Markets

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.